avandia

DRUG2 trials

Sponsors

GlaxoSmithKline, Brooke Army Medical Center

Conditions

Insulin ResistanceNonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis

Phase 2

Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

Brooke Army Medical CenterNonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis

Start: 2007-04-30End: 2009-08-31Target: 165Updated: 2009-06-19

Phase 3

Study In Patients With Insulin Resistance

CompletedNCT00197132

GlaxoSmithKlineInsulin Resistance

Start: 2002-10-31End: 2003-08-31Updated: 2016-12-05